SAN FRANCISCO and PARIS--(BUSINESS WIRE)-- SpineVision® announced today that preliminary data from an ongoing postmarketing study show that its FDA-cleared PediGuard™ device allows a two-fold reduction of the risk of inadvertent pedicle screw “misplacement” during lumbar degenerative spine surgery. In addition, the preliminary results show that the use of PediGuard leads to a six-fold reduction of medial breaches, and suggest an approximately 10 percent decrease in average screw-placement time, as well as a reduction of surgeons’ exposure to radiation by approximately 30 percent. The study’s final results are expected to be even more outstanding when the more challenging thoracic and deformity cases will be included.
